Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells - sprookjes - yvandenbroek - TriplyDB

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells

http://www.wikidata.org/entity/Q26852467

about

Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?The immune response of stem cells in subretinal transplantation Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells Stem Cells for Cutaneous Wound Healing Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs CD271+ Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum Therapeutic Strategies for Oxidative Stress-Related Cardiovascular Diseases: Removal of Excess Reactive Oxygen Species in Adult Stem Cells The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis.A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry.Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model Different culture conditions modulate the immunological properties of adipose stem cells.Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment Physical Activity Increases the Total Number of Bone-Marrow-Derived Mesenchymal Stem Cells, Enhances Their Osteogenic Potential, and Inhibits Their Adipogenic Properties Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.Uncovering stem cell differentiation factors for salivary gland regeneration by quantitative analysis of differential proteomes Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.Biomaterial-mediated strategies targeting vascularization for bone repair.Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis.Partial Cranial Cruciate Ligament Tears Treated with Stem Cell and Platelet-Rich Plasma Combination Therapy in 36 Dogs: A Retrospective Study.BPA-toxicity via superoxide anion overload and a deficit in β-catenin signaling in human bone mesenchymal stem cells.Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.Mesenchymal stem cells in treating autism: Novel insights.Stem cell therapy for cardiac regeneration: hits and misses.Human Mesenchymal Stromal Cell Sheet Enhances Allograft Repair in a Mouse Model Mesenchymal stromal cells in renal transplantation: opportunities and challenges.Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1/CCL2) in amniotic fluid derived-mesenchymal progenitor cells.Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain.Osteogenic potential of stem cells-seeded bioactive nanocomposite scaffolds: A comparative study between human mesenchymal stem cells derived from bone, umbilical cord Wharton's jelly, and adipose tissue.Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies.Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.Monitoring the ex-vivo expansion of human mesenchymal stem/stromal cells in xeno-free microcarrier-based reactor systems by MIR spectroscopy.Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells Crosstalk with Inflammatory Macrophages Shapes the Regulatory Properties of Multipotent Adult Progenitor Cells.CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice.Osteogenic Potential of Multipotent Adult Progenitor Cells for Calvaria Bone Regeneration.Fibrin Scaffolds Designing in order to Human Adipose-derived Mesenchymal Stem Cells Differentiation to Chondrocytes in the Presence of TGF-β3 Evaluating Wharton's Jelly-Derived Mesenchymal Stem Cell's Survival, Migration, and Expression of Wound Repair Markers under Conditions of Ischemia-Like Stress.Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process.The issue of immunology in stem cell therapies: a pharmaceutical perspective.

P2860

Q26766574-D12AD987-25F8-44EB-A35A-36151C143542 Q26781292-2731C7F4-33F7-407F-81C3-FEB36062AF49 Q26822005-13514AC0-14D0-46DF-A36E-665336188003 Q27025609-3767C315-6BE1-474C-9A49-FBDFB8E11415 Q27316366-9B7D22F3-8FDD-49AC-AC3A-AB5AE781680F Q27321912-88D7ADA0-01DC-49F8-B483-0802E642BE1B Q28077974-3CA8D49C-3949-4F64-A64E-E275F31DD1DC Q33577019-75AF1FDF-1B05-4793-A8FA-2F621A95397C Q33671117-54A4B766-4341-4E4C-9AB3-13C21D47D771 Q33872068-B7037B4F-6419-4902-B0B1-373F76DE62B8 Q34273076-AA886D03-F760-4F90-A158-857BA13A5FA0 Q34664183-FCA4D8D7-5404-4EA1-8350-106CA44A68FB Q35806824-698048C0-653C-4AB7-BF1A-5340373CB268 Q36070752-678B71DE-9805-41B8-BE72-178C142FD092 Q36269896-6EC5C4CC-227C-44A7-966C-B3EE7C3D8F71 Q36326838-18873A5E-6F02-4CFB-A1AE-808D980B86CD Q36326923-2A109505-CB1E-4650-87AC-3F2107482E15 Q36870064-B0CF64BE-C18F-4CC7-93E9-8C8E49EDCD03 Q37500590-5B69ECA6-C3F9-4C61-BEF9-F7051448F7E1 Q37565614-E1473B49-4E4C-4E04-84A8-C1BC99B6A6CC Q38110707-15A1023D-33EE-4381-A9ED-D4EEA8BA2CD0 Q38207602-60831BDD-E822-4846-AAA9-9B90E2B0A641 Q38601272-025E6FA8-86D3-4721-9597-BEBC752F5A93 Q38628091-C24C7850-4C84-4B11-8A2C-7FD6A6D34081 Q38725481-89B53872-5555-4B60-BEA0-DDF9D6120CF0 Q38816893-4413680E-155C-40B5-828B-01E620F1BE24 Q38928462-F54B3064-97AE-45E5-9312-376C15BD312A Q39174525-4B8376B1-D705-40EC-872C-A5812D741C93 Q39262680-8BFBAF53-44C7-4C25-AA82-5C612C2634DC Q40122051-20FA0A05-0240-4180-B1FE-686389DDC14E Q40173940-290B3C59-5D9E-4DB6-9179-97DC6C7B5CEE Q40214885-27D7B63E-5504-403B-A094-101808027C4C Q40400293-41AD7528-4AAB-4857-BF5E-188AD77A4CA2 Q41141797-E0F7F354-2D2F-4E97-9EE4-33EA57E21928 Q41191186-17AD351A-8B32-4AE1-A73B-57664B539579 Q41446638-C073155F-A19B-4F77-9246-8558EDEBA82D Q42214329-79B85A55-2A77-435C-9AA2-7EBB05D1767E Q42320604-207844FD-0507-47EA-A1BC-E52692AAFEED Q42406826-7601D1FC-CFE3-4329-9652-30613E5E3C43 Q42621315-FC6275D8-6C98-4EC7-9C96-53E68394DA22

P2860

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells

http://www.wikidata.org/entity/Q26852467

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Immunological characteristics ...... ipotent adult progenitor cells

@ast

Immunological characteristics ...... ipotent adult progenitor cells

@en

Immunological characteristics ...... ipotent adult progenitor cells

@nl

type

label

Immunological characteristics ...... ipotent adult progenitor cells

@ast

Immunological characteristics ...... ipotent adult progenitor cells

@en

Immunological characteristics ...... ipotent adult progenitor cells

@nl

prefLabel

Immunological characteristics ...... ipotent adult progenitor cells

@ast

Immunological characteristics ...... ipotent adult progenitor cells

@en

Immunological characteristics ...... ipotent adult progenitor cells

@nl

P1433

Q26852467-90BD9C1A-4E7E-4802-9485-A268C14D623F

P1476

Q26852467-8342509A-C219-4941-A78B-4CADD512EEE5

P2093

Q26852467-B795077B-9BBC-4D32-8F0C-7280A2FA9264

Q26852467-C5217BFB-76B7-4CEF-8A5F-62E13AD59C50

Q26852467-DFE10619-59CD-4006-A105-CF35AF15CFA6

P275

Q26852467-90696687-D4DB-4CC9-BB49-D763CEE06A3B

P2860

Q26852467-05C3CFC6-241A-44DE-AE36-472ABBAF4B8F

Q26852467-0BC83539-9985-4DAE-8958-A3BE2879B3CC

Q26852467-0F82C692-0CE2-4C89-9425-24794B962AD1

Q26852467-1298790A-156B-4E2A-B2B1-EBFA80411596

Q26852467-13D57F54-50BD-4FDB-BA9B-4FF827BD53C5

Q26852467-15C53BF0-4C6E-44E0-8F95-E7024DD628BE

Q26852467-16C0F33B-925B-4FB1-A638-858448476735

Q26852467-23CC5B09-BBFA-40AE-A746-70CC0FF6E97D

Q26852467-32A3AD1B-F5BB-4E0A-9CD5-FA6A316274EE

Q26852467-3B933C10-F511-41D0-A13A-18B4FF1757A7

P304

Q26852467-30575D5C-C05B-4622-86E2-CE6B8ED20FBB

P31

Q26852467-6039D23D-DB8F-483D-9C98-14FE1C2BF9C8

Q26852467-BB79DDAF-2EE3-4E6A-BA93-975397258181

P3181

Q26852467-4A95968B-98F6-4FD9-8835-E21E7B5232ED

P356

Q26852467-40D07443-2BFF-4104-924E-875A49849576

P407

Q26852467-865897C5-0687-4758-905F-D77FB8E68E4C

P433

Q26852467-8D670CC5-C17F-414D-BE5C-A4B967CD9A2F

P478

Q26852467-35D92C83-C807-4D63-8227-F85203FF9B62

P50

Q26852467-CF8AB714-3FC7-4F87-B572-45076BC925A9

P577

Q26852467-7A790B93-F34D-4683-844F-0E640E795642

Q26852467-EF390F42-AEFF-4807-AF1C-3479EF609617

P5875

Q26852467-755907F3-D065-4B4A-A5E7-F1B04C390BCA

P698

Q26852467-8884908F-E1C1-426D-AD25-A5B6DBBF598D

P921

Q26852467-344F72E7-293C-479D-94E3-304DDA8102EF

Q26852467-691DBBCE-22E0-4E7B-AFD2-7249DC9F5E61

Q26852467-B670DEE8-6CCD-461A-BB02-18B8AA3B7F91

Q26852467-BBF13C22-645E-426B-B585-950FB053E24A

Q26852467-F9982156-4798-4D23-976D-29BE0840E76A

P932

Q26852467-F8B27A86-9CE7-40CD-8B6C-D95D698C7E62

P3181

P356

P1433

Immunology & Cell Biology

P1476

Immunological characteristics ...... ipotent adult progenitor cells

@en

P2093

Sandra A Jacobs

http://www.w3.org/2001/XMLSchema#string

Stefaan W Van Gool

http://www.w3.org/2001/XMLSchema#string

Valerie D Roobrouck

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

P2860

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

A perivascular origin for mesenchymal stem cells in multiple human organs

Human mesenchymal stem cells modulate allogeneic immune cell responses

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Human adipose tissue is a source of multipotent stem cells

Pluripotency of mesenchymal stem cells derived from adult marrow

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

Mesenchymal stem cells as trophic mediators

P304

32-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2002200

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/ICB.2012.64

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P50

Catherine Verfaillie

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234086222

http://www.w3.org/2001/XMLSchema#string

P698

23295415

http://www.w3.org/2001/XMLSchema#string

P921

mesenchymal stem cells

bone marrow cells

hemic and immune systems

P932

3540326

http://www.w3.org/2001/XMLSchema#string